In conclusion, the results of the present study show that Rig-G inhibits lung cancer cell growth via MiR21/PTEN/Akt and miR181b-1/CYLD-dependent inhibition of NF-κB, which is associated with decreased STAT3 activity. This evidence concerns the gene CYLD and lung carcinoma.